| 000 | 01620 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514213911.0 | ||
| 264 | 0 | _c20050412 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a1462-8902 | ||
| 024 | 7 |
_a10.1111/j.1463-1326.2004.00363.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Leeuw, I | |
| 245 | 0 | 0 |
_aInsulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _cJan 2005 |
||
| 300 |
_a73-82 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Detemir |
| 650 | 0 | 4 |
_aInsulin, Isophane _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin, Long-Acting |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aVague, P | |
| 700 | 1 | _aSelam, J-L | |
| 700 | 1 | _aSkeie, S | |
| 700 | 1 | _aLang, H | |
| 700 | 1 | _aDraeger, E | |
| 700 | 1 | _aElte, J W F | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 7 _gno. 1 _gp. 73-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2004.00363.x _zAvailable from publisher's website |
| 999 |
_c15321804 _d15321804 |
||